my country's vaccine market is about to exceed 60 billion yuan, and more requirements will be placed on this industry

Recently, Fosun Pharma issued an announcement stating that in order to enrich the vaccine product pipeline, on the basis of the existing viral vaccine products, it will expand the stock of bacterial vaccine products
.
It is planned to use cash and 100% equity of Dalian Yalifeng as a controlling shareholder to acquire Antjin, with a total value of over 4 billion yuan
.
China's vaccine market is about to exceed 60 billion yuan (picture source: Pharmaceutical Network) The industry believes that such a large investment is because the vaccine industry market is very substantial
.
It is understood that in China, due to China's huge population base, with the increase of people's disposable income and the increase of people's awareness of vaccination, China's vaccine market is maintaining a rapid growth trend, and the overall market size is also expanding
.
According to statistics, the total scale of the domestic vaccine market has exceeded 50 billion yuan in 2020, reaching 51.
5 billion yuan, and is expected to exceed 60 billion yuan by 2021
.
At present, in the face of huge market prospects, in fact, pharmaceutical companies and capital are accelerating their deployment in the vaccine industry
.
According to the company's data, the number of registrations of vaccine-related companies in the past three years (2018-2020) has been above 1,500
.
Among them, the number of registrations in 2020 was 1,556, a year-on-year increase of 2.
8%
.
However, although China's vaccine industry is developing very rapidly, it still has huge room for development compared with some overseas countries
.
Therefore, in order to further support the development of the vaccine industry and ensure the supply of vaccines
.
The state has also issued a series of policies and regulations to promote the high-quality and accelerated development of the industry
.
In this way, the "Administrative Measures for Batch Issuance of Biological Products" issued by the State Municipal Supervision Bureau has further improved the management measures for the determination of the batch issuance of biological products, the application for batch issuance, and the review and inspection of biological products
.
It is expected that under the influence of many favorable policies, the domestic vaccine market will further expand in the future, attracting more powerful and innovative companies to join the game..
So when a large number of companies are accelerating their deployment in the vaccine market, what impact will it have on the upstream pharmaceutical equipment industry? According to the analysis, the production of vaccines generally requires fermentation, collection/inactivation, processing, preparation, and filling.
The main nodes are configuration and filling.
Considering the safety and quality of vaccines, vaccine companies have to With the continuous improvement of safety requirements, the requirements for related manufacturing and filling equipment will also increase
.
In addition, the requirements for pollution control and personnel protection in the R&D and production processes will also become more stringent
.
The author understands that in response to the above problems, many pharmaceutical equipment companies have begun to reform and innovate equipment for vaccine research and development, production, and storage to help the further development of the vaccine industry
.
If there is a company, it will provide a complete set of bioprocess solutions for domestic and foreign biopharmaceutical companies
.
From the hardware point of view, this process includes disposable bioreactors, equipment, and consumables for the production and development of vaccine products to provide high-precision technology
.
From the perspective of software, there is also a dedicated process analysis and control platform, with data and algorithms as the basis
.
It is worth mentioning that with the continuous efforts of pharmaceutical machinery companies, more and more high-end pharmaceutical equipment has also begun to appear in multiple processes such as vaccine filling and packaging quality inspection of pharmaceutical companies
.
For example, last year, Chutian Technology’s core equipment such as the washing-baking-filling-sealing linkage production line, intelligent testing equipment, and post-packaging production line ensured production with excellent operating performance, which played an important role in the sub-packaging of vaccine production in pharmaceutical companies and contributed to the large-scale production of vaccines.
, An important contribution to the increase in production capacity
.
In general, in the context of the continued expansion of the vaccine and vaccine market, pharmaceutical equipment is also expected to usher in opportunities
.
However, it should be noted that in the field of high-end vaccine manufacturing and filling equipment, China is still dominated by imported equipment.
There are still a few domestic companies that can provide high-end vaccine manufacturing and filling equipment; therefore, in order to further ensure vaccine safety and Production capacity, local pharmaceutical equipment companies must continue to innovate, improve production efficiency through continuous improvement of product technology, intelligence, and automation, and ensure the safety and control of product quality in vaccine production and storage
.